Questions across 4 calls

Deekshant B.

DB Wealth

Caplin Point Laboratories Limited

Caplin Point Laboratories Limited CC-Mar25.pdf · 2025-05-15

Hi, congratulations , sir, for decent results. Sir , firstly, we have been investing a lot on our capabilities to get more US FDA approvals and as well as we know that Caplin Steriles has been helping us grow and we are expanding our foothold in the U.S. markets. But can you help us understand that what sort of time period can we look at where the sign ificant growth is back in the business? We are going through a transformation even on our cost and the margins are looking better from a longer perspective. But what is it that is required from us to make the growth feel much more vibrant?

Sir, can you help us understand that , so from our understanding, whenever we are getting new US FDA approvals, we are also seeing that a better product composi tion is being launched by companies. What I really mean to ask you here is that the old products that we have , are they losing some sort of market share and they are being replaced by new ones or are we just the existing products, are they able to give us the similar kind of revenues that they were?

Caplin Point Laboratories Limited CC-Sep24.pdf · 2024-11-07

Congratulations on very good numbers. Sir, I have two questions. First one being on our expansion into the U.S. So, as we are discussing that we are now going to go more from the B2C route and approach the hospitals directly, which will aid our margins. Is this the first step we are taking towards the expansion to the B2B2C business? And is this the route that we are taking, which is also considering that we were thinking of maybe in the future going forward with sort of a CVS pharmacy thought process. I'm just giving CVS as an example. But is this the first step towards that thought process? Or is this separate and that is separate?

Yes. So, a couple of quarters ago, the Chairman sir has been talking about that we will be using our reserves maybe in the future, not immediately for like getting the right place to use our capital, and that may be into the retail business, not immediately. But my assumption is that the first step is to go 1 step down to directl y to hospitals. Is that the thought process? Could you please expand on this?

Netweb Technologies India Limited

Netweb Technologies India Limited CC-Dec24.pdf · 2025-01-20

Yes. Congratulations, sir, the rate growth by our company has really been commendable. I have 2 questions. Firstly, regarding -- with our remuneration package for our Chief Sales Officer, which is Mr. Hirdey. I understand that the growth is being driven by the great sales work done by the team. I want to also understand what part of his compensation package has ESOP structure linked to it?

Yes, sir. Sir, could you just expand a little bit on our R&D for 5G ORAN services?

Newgen Software Technologies Limited

Newgen Software Technologies Limited CC-Sep24.pdf · 2024-10-15

Congratulations on great numbers, sir. So, my first question is basically, since we are so much catered to the banking side of the business and we have helped them grow in a lot of ways, that's why they keep giving us good -- bigger deals. Can you just highlight one or two particular products that help our clients grow, that's why they are coming back to us. The idea of asking this question is for -- we can understand that what makes them keep coming back to us and growing this so that we can make this cycle bigger and bigger as the time goes by?

So, if I'm understanding you right, is this -- so basically, we are selling them a better efficiency for their team rather than helping them gain their sales directly. So, it's indirectly because their efficiency is slowing, their team is able to make more sales by increased efficiency. Is that the idea?